Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX®), which will become effective...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.24 | -0.608828006088 | 39.42 | 41.49 | 38.52 | 4104813 | 40.06708909 | CS |
4 | -4.23 | -9.74429854872 | 43.41 | 47.4126 | 37.44 | 7835917 | 41.30252454 | CS |
12 | -21.02 | -34.9169435216 | 60.2 | 60.65 | 35.8 | 7589004 | 44.88424188 | CS |
26 | -77.87 | -66.5271251602 | 117.05 | 129.3642 | 35.8 | 5905143 | 60.88301649 | CS |
52 | -60.79 | -60.8082424727 | 99.97 | 170.47 | 35.8 | 5055265 | 83.43897689 | CS |
156 | -204.65 | -83.931427634 | 243.83 | 259.1989 | 35.8 | 5058370 | 124.5920428 | CS |
260 | 19.64 | 100.511770727 | 19.54 | 497.17 | 17.68 | 9346233 | 145.31552714 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.